US 12012597
Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein
granted A61PA61P35/00
Quick answer
US patent 12012597 (Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein) held by ARIZ Precision Medicine, Inc. expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARIZ Precision Medicine, Inc.
- Grant date
- Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P35/00